CLOV vs IMRX
Clover Health Investments Corp (CLOV) versus Immuneering Corp (IMRX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Immuneering Corp (IMRX) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported IMRX revenue for 2023-12-31 was $0. Net income was -$53.5M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. IMRX currently screens at market cap $124.2M.
CLOV currently screens at market cap $1.55B. IMRX currently screens at market cap $124.2M.
Not investment advice. Open the CLOV and IMRX stock pages for the full models.
Not investment advice.